ALS EBITDA
Was ist das EBITDA von ALS?
EBITDA von ALS Limited ist AUD$443.800M
Was ist die Definition von EBITDA?
Das EBITDA ist das Ergebnis eines Unternehmens vor Zinsen, Steuern, Abschreibungen und Amortisationen und ist eine Buchhaltungsgröße, die anhand des Nettoergebnisses eines Unternehmens berechnet wird, bevor Zinsaufwendungen, Steuern, Abschreibungen und Amortisationen abgezogen werden, um die derzeitige operative Ertragskraft eines Unternehmens zu ermitteln.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA von Unternehmen in Industrials Sektor auf ASX im Vergleich zu ALS
Was macht ALS?
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, North Africa, and the Americas. The company operates through three segments: Commodities, Life Sciences, and Industrial. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality areas. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment also provides analytical testing data to assist consulting and engineering firms, industries, and governments. The Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Stafford, Australia.
Unternehmen mit ebitda ähnlich ALS
- Mangalam Drugs & Organics hat EBITDA von ₨442.240M
- Ultra Petroleum hat EBITDA von $442.503M
- Ultra Petroleum hat EBITDA von $442.503M
- Wendt (India) hat EBITDA von ₨442.930M
- Accuracy Shipping hat EBITDA von ₨442.982M
- Dawnrays Pharmaceutical () hat EBITDA von ¥443.042M
- ALS hat EBITDA von AUD$443.800M
- Luoyang Glass hat EBITDA von ¥443.817M
- Acrysil hat EBITDA von ₨443.957M
- Armstrong World Industries hat EBITDA von $444.000M
- Sopra Steria SA hat EBITDA von €444.800M
- Dhunseri Investments hat EBITDA von ₨444.867M
- Kokuyo Camlin hat EBITDA von ₨444.942M